Nestle, the world’s major food company, is setting up a unit to develop personalized nutrition products to help treat or prevent diabetes, obesity, cardiovascular disease, and Alzheimer’s. Luis Cantarell, who leads Nestle’s trade in the Americas, will be chief executive of Nestle Health Science, the company said yesterday. Nestle can use cash from a sale last month to fund research and takeover to become a leader in foods that aim health needs, surpassing Groupe Danone, said Jean-Marie L’Home, an analyst at Aurel in Paris. Nestle received $28.3 billion from Novartis previous month for a majority stake in the Alcon eye-care division. “Nestle will probably be the leader in this group within the next few years,’’ he said.
Nestle is establishing the new separation as regulators increase their scrutiny of health-benefits promotions. Danone, whose medical nutrition unit had sales of $1.2 billion in 2009, withdrew application to the European Food Safety right for its Actimel yogurt drinks’ health claims, saying it needs clarity on the rules. Nestle’s new unit will include its obtainable health care nutrition business, which had sales of $1.6 billion last year, the manufacturer said. The company is also creating the Nestle Institute of Health Sciences, an organization to be base at Ecole Polytechnique Federale de Lausanne, a research partner. Emmanuel Baetge, former chief scientific officer of ViaCyte, a San Diego, Calif., company that is raising diabetes treatments from stem cells, will lead the research institute.
useful links : transport rankings
Nestle is establishing the new separation as regulators increase their scrutiny of health-benefits promotions. Danone, whose medical nutrition unit had sales of $1.2 billion in 2009, withdrew application to the European Food Safety right for its Actimel yogurt drinks’ health claims, saying it needs clarity on the rules. Nestle’s new unit will include its obtainable health care nutrition business, which had sales of $1.6 billion last year, the manufacturer said. The company is also creating the Nestle Institute of Health Sciences, an organization to be base at Ecole Polytechnique Federale de Lausanne, a research partner. Emmanuel Baetge, former chief scientific officer of ViaCyte, a San Diego, Calif., company that is raising diabetes treatments from stem cells, will lead the research institute.
useful links : transport rankings
No comments:
Post a Comment